samedan logo
 
 
spacer
home > ict > Winter 2014
PUBLICATIONS

International Clinical Trials

ict
Winter 2014

   
Text
PDF
Comment from the Editor

A turning point for antibiotics, diagnostics partners and patient motivation – Graham Hughes picks out a few of the articles and themes from this edition.
 
view
download pdf
bullet
Regulatory & Business Practice
Antibiotics R&D

Back to Health

A turbulent period for antibiotics development could be drawing to a close. Jon Bruss and Brian Murphy at Medpace describe how the public health crisis over multi-drug resistance has triggered an R&D surge by smaller biotechs and regulators.
 
view
download pdf
bullet
TRIAL MANAGEMENT
Companion Diagnostics

Breaking News

Pharma has struggled to live up to the lofty goals set for companion diagnostics but, as Alan Wookey at LabCorp predicts, increasing collaborations and a regulatory rethink of laboratory-developed tests have heightened expectations that more approvals are coming.
 
view
download pdf
Adaptive Designs

Changing Priorities


Growing steadily over the last decade, adaptive designs are being used for studies across industry and considered for new treatment assignments. Shyama Ghosh and Alvaro Arjona at Thomson Reuters provide an update on their use.
 
view
download pdf
Study Feasibility

Get Started


The cornerstone of a successful clinical trial, feasibility assessment enables CROs to address risks and delays in start-up and patient enrolment before a study begins. A Savateyev, M Belotserkovsky, D Palumbo and K Moscicka at PSI explain.
 
view
download pdf
Sample Integrity

Piece of the Action


As vital scientific assets for current and future research, clinical trial samples must be properly handled, from collection to transport to storage. Lori Ball of BioStorage Technologies makes the case for a strategic sample management plan to be considered upfront in the study design.
 
view
download pdf
bullet
Clinical Trial Outsourcing
PCT Congress 2013

Strategic Review


Assessing the future outsourcing landscape, the recent Partnerships in Clinical Trials Congress found that, despite some successes, the tensions and differences between sponsors and CROs continue to hamper a truly strategic approach. Graham Hughes reports.
 
view
download pdf
Functional Services

Pick and Choose


Functional service provider partnerships appear the way ahead for some sponsors, with this ‘cafeteria’ style of outsourcing specific services proving more flexible than full-service models. Dawn Edgerton from Rho gives some advice on finding CROs that are the right fit.
 
view
download pdf
bullet
eCLINICAL
Patient Engagement

Personal Touch

‘Bring your own device’ technology is the next step for pharma as it continues to harness mobile and digital platforms to enhance patient engagement and adherence in trials. Judith Teall at Exco InTouch explores how familiarity breeds success.
 
view
download pdf
bullet
Clinical Trial Supply & Packaging
Investigational Products

Patient Voices


The first-ever survey of patient experiences with investigational medicinal products reveals high levels of satisfaction, while also pointing to the need for more customised materials. Esther Sadler-Williams and Michelle Foust from ISPE’s project team outline the findings.
 
view
download pdf
bullet
CLINICAL THERAPEUTICS
Alternative Medicine

Yes, we CAM

From mind-body medicine to vitamin supplements, complementary and alternative treatments are gaining in popularity – prompting the need for greater awareness of how they interact with products and patients in trials. Marcin and Martyna Stefanowicz at Trial-Med explain.
 
view
download pdf
bullet
Trial Management & Outsourcing
Translation Services

About Time


Despite widespread outsourcing of translation services, pharma is still being hit by additional layers of cost and resources stemming from the handling and verification of translated documents. Matan Topper-Erez at TransCom Global recommends some new practices.
 
view
download pdf
bullet
Regional trials
Outsourcing: Southeast Asia

Into the East


Building on its Phase 2 and 3 capabilities, Southeast Asia is improving its early-stage trial set-up, infrastructure and regulation – making this fast-expanding market a winning ticket for multinational pharma. Nick Beckett and David Pountney at CMS set the scene.
 
view
download pdf
bullet
data management & statistical analysis
Risk-Based Monitoring

Vital Statistics


Increasingly favoured by regulators, central statistical monitoring can better interrogate study data, identifying anomalies early while also minimising risks and costs. Little wonder, says Marc Buyse at CluePoints, that it looks set to overtake traditional site-based practices.
 
view
download pdf
Clinical Trial Software

Level Best


Abraham Gutman at AG Mednet looks forward to the evolution of trial software, with the industry primed to further refi ne systems to take imaging data and more advanced analytics into new territory.
 
view
download pdf

Patient Recruitment and Retention
Study Retention

Staying on Course


Given that upwards of 40 per cent of subjects can stop their participation in a trial, retention is surprisingly overlooked. Elizabeth Puller and Liz Moench at MediciGlobal offer some tips on how to shape an effective retention programme to ensure a study remains on track.
 
view
download pdf

Interview
Industry Interview

Digital Direction

Nick Halkitis from Access to Patients tells ICT how digital recruitment and multi-channel marketing are coming to the rescue of clinical trials.
 
view
download pdf
Industry Interview

Source Code

Flexibility and know-how before, during and after a study are necessary to ensure comparator sourcing stays ahead of the game, advises Nadia Whittley of Pharmarama.
 
view
download pdf
Industry Interview

Thinking Allowed


Nuala Murphy, ICON Clinical Services’ new President, outlines how effort, expertise and technology support strong business decisions.
 
view
download pdf
   
spacer


Published quarterly in
February, May,
August, and November

News and Press Releases

SGS Enrolls First Patient into Biophytis’ COVA Clinical Study, a COVID-19 Clinical Trial

SGS was chosen by French biotech company Biophytis to conduct its COVA study – a Clinical Trial with Sarconeos (BIO101) for the Treatment of Patients with COVID-19 Related Respiratory Failure.
More info >>

White Papers

A Rules Based Approach to Labelling and Artwork Management

Kallik

Many organisations today are experiencing unprecedented demands from regulatory authorities and consumers alike for product labelling to be made clearer and more informative. Forthcoming regulations (including the new EU MDR regulations coming into force May 2020) also require that labelling content to be published electronically in addition to print. As companies seek to continuously differentiate themselves in established markets as well as gain entry into new territories, the increase in both volume and complexity of product and market variations will have a direct impact on labelling.
More info >>

Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement